Literature DB >> 25079538

Cancer biomarkers: Written in blood.

Ed Yong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25079538     DOI： 10.1038/511524a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Presence of fetal DNA in maternal plasma and serum.

Authors:  Y M Lo; N Corbetta; P F Chamberlain; V Rai; I L Sargent; C W Redman; J S Wainscoat
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

2.  Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

Authors:  Tim Forshew; Muhammed Murtaza; Christine Parkinson; Davina Gale; Dana W Y Tsui; Fiona Kaper; Sarah-Jane Dawson; Anna M Piskorz; Mercedes Jimenez-Linan; David Bentley; James Hadfield; Andrew P May; Carlos Caldas; James D Brenton; Nitzan Rosenfeld
Journal:  Sci Transl Med       Date:  2012-05-30       Impact factor: 17.956

3.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

4.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

5.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

6.  Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.

Authors:  V Vasioukhin; P Anker; P Maurice; J Lyautey; C Lederrey; M Stroun
Journal:  Br J Haematol       Date:  1994-04       Impact factor: 6.998

7.  Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.

Authors:  Muhammed Murtaza; Sarah-Jane Dawson; Dana W Y Tsui; Davina Gale; Tim Forshew; Anna M Piskorz; Christine Parkinson; Suet-Feung Chin; Zoya Kingsbury; Alvin S C Wong; Francesco Marass; Sean Humphray; James Hadfield; David Bentley; Tan Min Chin; James D Brenton; Carlos Caldas; Nitzan Rosenfeld
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

8.  Soluble normal and mutated DNA sequences from single-copy genes in human blood.

Authors:  G D Sorenson; D M Pribish; F H Valone; V A Memoli; D J Bzik; S L Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

9.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

10.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962
View more
  55 in total

1.  Machine learning can accelerate discovery and application of cyber-molecular cancer diagnostics.

Authors:  David S Campo; Yury Khudyakov
Journal:  J Med Artif Intell       Date:  2020-03

2.  A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma.

Authors:  Guozhu Xie; Di Gu; Lanfang Zhang; Shijun Chen; Dehua Wu
Journal:  Cancer Biol Ther       Date:  2017-06-30       Impact factor: 4.742

3.  Rebuttal from Dr. Hofman and Dr. Ilié.

Authors:  Marius Ilié; Paul Hofman
Journal:  Transl Lung Cancer Res       Date:  2016-08

Review 4.  High-Definition Medicine.

Authors:  Ali Torkamani; Kristian G Andersen; Steven R Steinhubl; Eric J Topol
Journal:  Cell       Date:  2017-08-24       Impact factor: 41.582

Review 5.  Liquid biopsy in early stage lung cancer.

Authors:  Cristina Pérez-Ramírez; Marisa Cañadas-Garre; Ana I Robles; Miguel Ángel Molina; María José Faus-Dáder; Miguel Ángel Calleja-Hernández
Journal:  Transl Lung Cancer Res       Date:  2016-10

6.  Gene methylation in liquid biopsy and risk of recurrence in lung cancer.

Authors:  Pasqualino de Antonellis; Antonella De Luca; Nicola Normanno
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma.

Authors:  Melanie A Krook; Alexandria Lenyo; Max Wilberding; Hannah Barker; Mikayla Dantuono; Kelly M Bailey; Hui-Zi Chen; Julie W Reeser; Michele R Wing; Jharna Miya; Eric Samorodnitsky; Amy M Smith; Thuy Dao; Dorrelyn M Martin; Kristen K Ciombor; John Hays; Aharon G Freud; Sameek Roychowdhury
Journal:  Mol Cancer Ther       Date:  2020-01-07       Impact factor: 6.261

Review 8.  Application of liquid biopsy in precision medicine: opportunities and challenges.

Authors:  Junyun Wang; Shuang Chang; Guochao Li; Yingli Sun
Journal:  Front Med       Date:  2017-07-25       Impact factor: 4.592

Review 9.  Circulating tumor DNA in colorectal cancer: opportunities and challenges.

Authors:  Feifei Bi; Qiwei Wang; Qian Dong; Yuanhe Wang; Liqun Zhang; Jingdong Zhang
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

10.  Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

Authors:  Clemens Hufnagl; Michael Leisch; Lukas Weiss; Thomas Melchardt; Martin Moik; Daniela Asslaber; Geisberger Roland; Philipp Steininger; Thomas Meissnitzer; Daniel Neureiter; Richard Greil; Alexander Egle
Journal:  Oncol Lett       Date:  2019-12-09       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.